Possible role of edotecarin, a novel topoisomerase I inhibitor, in theraphy-related myelodysplastic syndrome Journal Article
| Authors: | Carvajal, R. D.; Ilson, D.; Noy, A. |
| Article Title: | Possible role of edotecarin, a novel topoisomerase I inhibitor, in theraphy-related myelodysplastic syndrome |
| Keywords: | adult; acute granulocytic leukemia; clinical feature; histopathology; neutropenia; case report; squamous cell carcinoma; carcinoma, squamous cell; cisplatin; fluorouracil; drug dose reduction; antineoplastic agents; cancer staging; positron emission tomography; follow up; antineoplastic agent; letter; computer assisted tomography; multiple cycle treatment; thrombocytopenia; drug antagonism; myelodysplastic syndrome; fluorescence in situ hybridization; chemically induced disorder; platinum derivative; indoles; mitomycin; indole derivative; patient attitude; lymph node biopsy; lymphadenopathy; myelodysplastic syndromes; cytodiagnosis; blood smear; dna topoisomerase; dna topoisomerases, type i; carbazoles; anus neoplasms; anus tumor; anus carcinoma; carbazole derivative; edotecarin; erythrocyte concentrate |
| Journal Title: | Leukemia and Lymphoma |
| Volume: | 48 |
| Issue: | 1 |
| ISSN: | 1042-8194 |
| Publisher: | Taylor & Francis Group |
| Date Published: | 2007-01-01 |
| Start Page: | 192 |
| End Page: | 194 |
| Language: | English |
| DOI: | 10.1080/10428190600968350 |
| PUBMED: | 17325867 |
| PROVIDER: | scopus |
| DOI/URL: | |
| Notes: | --- - "Export Date: 17 November 2011" - "CODEN: LELYE" - "Source: Scopus" |
Altmetric
Citation Impact
BMJ Impact Analytics
